Literature DB >> 30697

Protective ability of Salmonella ribosomal protein and RNA in inbred mice.

M L Misfeldt, W Johnson.   

Abstract

Ribosomal vaccines prepared from Salmonella typhimurium were effective immunogens in A/J, C3H/HeDub, and C3H/HeJ mice. Purified ribosomal components were also tested as immunogens in the inbred mice. Protein isolated from a Salmonella ribosomal fraction could protect all three mouse strains. Although purified RNA was shown to be protective for A/J and C3H/HeDub mice, it was not protective for C3H/HeJ mice. Protective immunity could be induced in A/J and C3H/HeDub mice by various immunostimulants. Immunity in C3H/HeJ mice, however, could only be induced by Salmonella ribosomes or protein isolated from the Salmonella ribosomal fraction.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 30697      PMCID: PMC421988          DOI: 10.1128/iai.21.1.286-291.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Humoral immunity to Streptococcus pneumoniae induced by a pneumococcal ribosomal protein fraction.

Authors:  C L Swendsen; W Johnson
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

2.  Extraction and isolation of individual ribosomal proteins from Escherichia coli.

Authors:  S Fogel; P S Sypherd
Journal:  J Bacteriol       Date:  1968-08       Impact factor: 3.490

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Protection against Toxoplasma gondii in mice immunized with Toxoplasma cell fractions, RNA and synthetic polyribonucleotides.

Authors:  F G Araujo; J S Remington
Journal:  Immunology       Date:  1974-10       Impact factor: 7.397

5.  Inhibition of multiplication of Mycobacterium leprae by polyinosinic-polycytidylic acid.

Authors:  L Levy; T C Merigan
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

6.  Role of endotoxin contamination in ribiosomal vaccines prepared from Salmonella typhimurium.

Authors:  M L Misfeldt; W Johnson
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

7.  Ribosomal vaccines. II. Specificity of the immune response to ribosomal ribonucleic acid and protein isolated from Salmonella typhimurium.

Authors:  W Johnson
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

8.  Effect of nonspecific stimulation on the defense mechanisms of inbred mice.

Authors:  S Medina; S I Vas; H G Robson
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

9.  Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium.

Authors:  M R Venneman; N J Bigley
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

10.  Ribosomal vaccines. I. Immunogenicity of ribosomal fractions isolated from Salmonella typhimurium and Yersinia pestis.

Authors:  W Johnson
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

View more
  10 in total

1.  T-cell-independent macrophage activation in mice induced with rRNA from Listeria monocytogenes and dimethyldioctadecylammonium bromide.

Authors:  J F van den Bosch; I Y Kanis; A C Antonissen; W A Buurman; C P van Boven
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

2.  A broadly applicable approach to T cell epitope identification: application to improving tumor associated epitopes and identifying epitopes in complex pathogens.

Authors:  Michael D Valentino; C Siddiq Abdul-Alim; Zachary J Maben; Denise Skrombolas; Lucinda L Hensley; Thomas H Kawula; Michelle Dziejman; Edith M Lord; Jeffrey A Frelinger; John G Frelinger
Journal:  J Immunol Methods       Date:  2011-08-18       Impact factor: 2.303

3.  Protection of C3H/HeJ mice from lethal Salmonella typhimurium LT2 infection by immunization with lipopolysaccharide-lipid A-associated protein complexes.

Authors:  J W Killion; D C Morrison
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

4.  Ribonuclease-sensitive ribosomal vaccines.

Authors:  R Gonggrijp; A C Antonissen; J F van den Bosch; C P van Boven
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

5.  Antibacterial resistance, macrophage influx, and activation induced by bacterial rRNA with dimethyldioctadecylammonium bromide.

Authors:  R Gonggrijp; W J Mullers; H F Dullens; C P van Boven
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

6.  RNase-sensitive and RNase-insensitive protective components isolated from Listeria monocytogenes.

Authors:  A C Antonissen; P J Lemmens; R Gonggrijp; J F van den Bosch; C P van Boven
Journal:  Antonie Van Leeuwenhoek       Date:  1985       Impact factor: 2.271

7.  Identification of protective cell surface proteins in ribosomal fractions from Salmonella typhimurium.

Authors:  M L Misfeldt; W Johnson
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

8.  Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity of Klebsiella pneumoniae ribosomal preparations.

Authors:  M M Riottot; J M Fournier; H Jouin
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

9.  Evidence for the presence of lipopolysaccharide in a ribonuclease-sensitive ribosomal vaccine of Pseudomonas aeruginosa.

Authors:  R Gonggrijp; M P Volleberg; P J Lemmens; C P van Boven
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

Review 10.  Pathogenesis and immunity in murine salmonellosis.

Authors:  H S Hsu
Journal:  Microbiol Rev       Date:  1989-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.